nach oben

Erschienen in:

03.01.2021 | Original Article

Diagnostic accuracy of clinical visualization and light-based tests in precancerous and cancerous lesions of the oral cavity and oropharynx: a systematic review and meta-analysis

verfasst von: María Rosa Buenahora, Alberto Peraza-L, David Díaz-Báez, Jairo Bustillo, Iván Santacruz, Tamy Goretty Trujillo, Gloria Inés Lafaurie, Leandro Chambrone

Erschienen in: Clinical Oral Investigations | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

Evaluate and compare the performance of autofluorescence, chemiluminescence, and clinical visual examination in the detection of oral potentially malignant disorders (OPMD), oral cancer (OC), and oropharyngeal cancer (OPC).

Materials and methods

A systematic review with meta-analysis based on diagnostic test studies. A literature search was carried out in the MEDLINE and EMBASE databases through August 30, 2020. For this review, the quality assessment tool of diagnostic precision studies (QUADAS-2) was used. Hierarchical regression models were used to estimate pooled diagnostic precision values in a random effects model.

Results

A total of 40 studies were identified for this review according to each test evaluated: 5.562 samples for autofluorescence, 1.353 samples for chemiluminescence, and 1.892 samples for clinical examination. The summary measures sensitivity and specificity of the clinical examination were 63% and 78%, respectively, AUC = 0.78 95% CI (0.74–0.81). In the autofluorescence test, these were 86% and 72%, respectively, AUC = 0.86 95% CI (0.83–0.89); and the chemiluminescent test were 67% and 48%, respectively, AUC = 0.59 95% CI (0.54–0.63)

Conclusions

Autofluorescence devices displayed superior accuracy levels in the identification of premalignant lesions and early neoplastic changes compared to clinical examination and chemiluminescent test. Overall, biopsy remains the gold standard for the definitive diagnosis of OPMD, OC, and OPC.

Clinical Relevance

Light-based clinical methods such as autofluorescence and chemiluminescence techniques have been used in clinical diagnosis for the differentiation of OPMD and malignant and benign lesions; although detailed visual examination appears to be effective in identifying, previous systematic reviews have not evaluated a relevant number of studies and they did not evaluate the accuracy of the clinical examination.

Nur mit Berechtigung zugänglich

Hussein AA, Helder MN, de Visscher JG, Leemans CR, Braakhuis BJ, de Vet HCW, Forouzanfar T (2017) Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer 82:115–127. https://doi.org/10.1016/j.ejca.2017.05.026CrossRefPubMed

Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML (2013) Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31:4550–4559. https://doi.org/10.1200/JCO.2013.50.3870CrossRefPubMedPubMedCentral

Awadallah M, Idle M, Patel K, Kademani D (2018) Management update of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol 125:628–636. https://doi.org/10.1016/j.oooo.2018.03.010CrossRefPubMed

Warnakulasuriya S, Johnson NW, van der Waal I (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36:575–580. https://doi.org/10.1111/j.1600-0714.2007.00582.xCrossRefPubMed

Hwang JTK, Gu YR, Shen M, Ralhan R, Walfish PG, Pritzker KPH, Mock D (2017) Individualized five-year risk assessment for oral premalignant lesion progression to cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 123(3):374–381. https://doi.org/10.1016/j.oooo.2016.11.004CrossRefPubMed

Awan KH, Morgan PR, Warnakulasuriya S (2015) Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation. Clin Oral Investig 19:2267–2272. https://doi.org/10.1007/s00784-015-1457-9CrossRefPubMed

Nair DR, Pruthy R, Pawar U, Chaturvedi P (2012) Oral cancer: premalignant conditions and screening--an update. J Cancer Res Ther 8(Suppl 1):S57–S66. https://doi.org/10.4103/0973-1482.92217CrossRefPubMed

Diamanti N, Duxbury AJ, Ariyaratnam S, Macfarlane TV (2002) Attitudes to biopsy procedures in general dental practice. Br Dent J 192:588–592. https://doi.org/10.1038/sj.bdj.4801434CrossRefPubMed

Tyagi KK, Khangura RK, Grewal DS, Salgotra V (2017) Knowledge, attitude and practices of general dental practitioners towards oral biopsy in Ghaziabad, Uttar Pradesh. International Journal of Contemporary Medicine Surgery and Radiology. Int J Contemp Med Surg Radiol 1:5–9

10.

Carreras-Torras C, Gay-Escoda C (2015) Techniques for early diagnosis of oral squamous cell carcinoma: systematic review. Med Oral Patol Oral Cir Bucal 20(3):e305–e315. https://doi.org/10.4317/medoral.20347CrossRefPubMedPubMedCentral

11.

Mota-Ramírez A, Silvestre FJ, Simó JM (2007) Oral biopsy in dental practice. Med Oral Patol Oral Cir Bucal 12(7):E504–E510PubMed

12.

Croce AC, Bottiroli G (2014) Autofluorescence spectroscopy and imaging: a tool for biomedical research and diagnosis. Eur J Histochem 58(4):2461. https://doi.org/10.4081/ejh.2014.2461CrossRefPubMedPubMedCentral

13.

Giovannacci I, Magnoni C, Vescovi P, Painelli A, Tarentini E, Meleti M (2019) Which are the main fluorophores in skin and oral mucosa? A review with emphasis on clinical applications of tissue autofluorescence. Arch Oral Biol 105:89–98. https://doi.org/10.1016/j.archoralbio.2019.07.001CrossRefPubMed

14.

Shashidara R, Sreeshyla HS, Sudheendra US (2014) Chemiluminescence: a diagnostic adjunct in oral precancer and cancer: a review. J Cancer Res Ther 10:487–491. https://doi.org/10.4103/0973-1482.138215CrossRefPubMed

15.

Mercadante V, Paderni C, Campisi G (2012) Novel non-invasive adjunctive techniques for early oral cancer diagnosis and oral lesions examination. Curr Pharm Des 18(34):5442–5451. https://doi.org/10.2174/138161212803307626CrossRefPubMed

16.

Altman DG, Bland JM (1994) Diagnostic tests 2: predictive values. BMJ 309(6947):102. https://doi.org/10.1136/bmj.309.6947.102CrossRefPubMedPubMedCentral

17.

Kim KW, Lee J, Choi SH, Huh J, Park SH (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers–part I. general guidance and tips. Korean J Radiol 16(6):1175–1187. https://doi.org/10.3348/kjr.2015.16.6.1175CrossRefPubMedPubMedCentral

18.

Lee J, Kim KW, Choi SH, Huh J, Park SH (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers–part II. Statistical methods of meta-analysis. Korean J Radiol 16(6):1188–1196. https://doi.org/10.3348/kjr.2015.16.6.1188CrossRefPubMedPubMedCentral

19.

Cicciù M, Cervino G, Fiorillo L, D’Amico C, Oteri G, Troiano G, Zhurakivska K, Lo Muzio L, Herford AS, Crimi S, Bianchi A, di Stasio D, Rullo R, Laino G, Laino L (2019) Early diagnosis on oral and potentially oral malignant lesions: a systematic review on the Velscope® fluorescence method. Dent J 7(3):93. https://doi.org/10.3390/dj7030093CrossRef

20.

Awan KH, Patil S (2015) Efficacy of autofluorescence imaging as an adjunctive technique for examination and detection of oral potentially malignant disorders: a Systematic Review. J Contemp Dent Pract 16(9):744–749. https://doi.org/10.5005/jp-journals-10024-1751CrossRefPubMed

21.

Nagi R, Reddy-Kantharaj YB, Rakesh N, Janardhan-Reddy S, Sahu S (2016) Efficacy of light based detection systems for early detection of oral cancer and oral potentially malignant disorders: systematic review. Med Oral Patol Oral Cir Bucal 21(4):e447–e455. https://doi.org/10.4317/medoral.21104CrossRefPubMedPubMedCentral

22.

Macey R, Walsh T, Brocklehurst P, Kerr AR, Liu JL, Lingen MW, Ogden GR, Warnakulasuriya S, Scully C (2015) Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev 5:CD010276. https://doi.org/10.1002/14651858.CD010276.pub2CrossRef

23.

Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MMG, Sterne JAC, Bossuyt PMM (2011) Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536. https://doi.org/10.7326/0003-4819-155-8-201110180-00009CrossRefPubMed

24.

Chainani-Wu N, Madden E, Cox D, Sroussi H, Epstein J, Silverman S (2015) Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions. Oral Dis 21(7):879–885. https://doi.org/10.1111/odi.12358CrossRefPubMed

25.

Mojsa I, Kaczmarzyk T, Zaleska M, Stypulkowska J, Zapala-Pospiech A, Sadecki D (2012) Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions. J Craniofac Surg 23:e162–e164. https://doi.org/10.1097/SCS.0b013e31824cdbeaCrossRefPubMed

26.

Kaur J, Jacobs R (2015) Combination of autofluorescence imaging and salivary protoporphyrin in oral precancerous and cancerous lesions: Non-invasive tools. J Clin Exp Dent 7(2):e187–e191. https://doi.org/10.4317/jced.52100CrossRefPubMedPubMedCentral

27.

Lalla Y, Matias MAT, Farah CS (2016) Assessment of oral mucosal lesions with autofluorescence imaging and reflectance spectroscopy. J Am Dent Assoc 147(8):650–660. https://doi.org/10.1016/j.adaj.2016.03.013CrossRefPubMed

28.

Moro A, De Waure C, Di Nardo F et al (2015) The GOCCLES® medical device is effective in detecting oral cancer and dysplasia in dental clinical setting. Results from a multicentre clinical trial. Acta Otorhinolaryngol Ital 35(6):449–454. https://doi.org/10.14639/0392-100X-922CrossRefPubMedPubMedCentral

29.

Scheer M, Fuss J, Derman MA, Kreppel M, Neugebauer J, Rothamel D, Drebber U, Zoeller JE (2016) Autofluorescence imaging in recurrent oral squamous cell carcinoma. Oral Maxillofac Surg 20(1):27–33. https://doi.org/10.1007/s10006-015-0520-7CrossRefPubMed

30.

Simonato L, Tomo S, Miyahara GI, Navarro R, Villaverde A (2017) Fluorescence visualization efficacy for detecting oral lesions more prone to be dysplastic and potentially malignant disorders: a pilot study. Photodiagn Photodyn Ther 17:1–4. https://doi.org/10.1016/j.pdpdt.2016.10.010CrossRef

31.

Awan KH, Morgan PR, Warnakulasuriya S (2011) Evaluation of an autofluorescence based imaging system (VELscopeTM) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol 47(4):274–277. https://doi.org/10.1016/j.oraloncology.2011.02.001CrossRefPubMed

32.

Farah CS, McIntosh L, Georgiou A, McCullough MJ (2012) Efficacy of tissue autofluorescence imaging (velscope) in the visualization of oral mucosal lesions. Head Neck 34(6):856–862. https://doi.org/10.1002/hed.21834CrossRefPubMed

33.

Güneri P, Epstein JB, Kaya A, Veral A, Kazandi A, Boyacioglu H (2011) The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions. Int J Oral Maxillofac Surg 40(2):155–161. https://doi.org/10.1016/j.ijom.2010.10.022CrossRefPubMed

34.

Jayanthi JL, Subhash N, Stephen M, Philip EK, Beena VT (2011) Comparative evaluation of the diagnostic performance of autofluorescence and diffuse reflectance in oral cancer detection: a clinical study. J Biophotonics 4(10):696–706. https://doi.org/10.1002/jbio.201100037CrossRefPubMed

35.

Mashberg A (1980) Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III. Cancer 46(4):758–763. https://doi.org/10.1002/1097-0142(19800815)46:4<758::AID-CNCR2820460420>3.0.CO;2-8CrossRefPubMed

36.

Moro A, Di Nardo F, Boniello R, Marianetti TM, Cervelli D, Gasparini G, Pelo S (2010) Autofluorescence and early detection of mucosal lesions in patients at risk for oral cancer. J Craniofac Surg 1(6):1899–1903. https://doi.org/10.1097/SCS.0b013e3181f4afb4CrossRef

37.

Rahman MS, Ingole N, Roblyer D, Stepanek V, Richards-Kortum R, Gillenwater A, Shastri S, Chaturvedi P (2010) Evaluation of a low-cost, portable imaging system for early detection of oral cancer. Head Neck Oncol 2:10. https://doi.org/10.1186/1758-3284-2-10CrossRefPubMedPubMedCentral

38.

Scheer M, Neugebauer J, Derman A, Fuss J, Drebber U, Zoeller JE (2011) Autofluorescence imaging of potentially malignant mucosa lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2:10–577. https://doi.org/10.1016/j.tripleo.2010.12.010CrossRef

39.

Bhatia N, Matias MAT, Farah CS (2014) Assessment of a decision making protocol to improve the efficacy of VELscopeTM in general dental practice: a prospective evaluation. Oral Oncol 50(10):1012–1019. https://doi.org/10.1016/j.oraloncology.2014.07.002CrossRefPubMed

40.

Chaudhry A, Manjunath M, Ashwatappa D, Krishna S, Krishna AG (2016) Comparison of chemiluminescence and toluidine blue in the diagnosis of dysplasia in leukoplakia: a cross-sectional study. J Investig Clin Dent 7(2):132–140. https://doi.org/10.1111/jicd.12141CrossRefPubMed

41.

Hanken H, Kraatz J, Smeets R, Heiland M, Blessmann M, Eichhorn W, Clauditz TS, Gröbe A, Kolk A, Rana M (2013) The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscopeTM) - a single blinded clinical evaluation. Head Face Med 9:23. https://doi.org/10.1186/1746-160X-9-23CrossRefPubMedPubMedCentral

42.

Kämmerer PW, Rahimi-Nedjat RK, Ziebart T, Bemsch A, Walter C, Al-Nawas B, Koch FP (2015) A chemiluminescent light system in combination with toluidine blue to assess suspicious oral lesions—clinical evaluation and review of the literature. Clin Oral Investig 19(2):459–466. https://doi.org/10.1007/s00784-014-1252-zCrossRefPubMed

43.

Marzouki HZ, Vu TTV, Ywakim R, Chauvin P, Hanley J, Kost KM (2012) Use of fluorescent light in detecting malignant and premalignant lesions in the oral cavity: a prospective, single-blind study. J Otolaryngol Head Neck Surg 41(3):164–168. https://doi.org/10.2310/7070.2012.00022CrossRefPubMed

44.

Petruzzi M, Lucchese A, Nardi GM, Lauritano D, Favia G, Serpico R, Grassi FR (2014) Evaluation of autofluorescence and toluidine blue in the differentiation of oral dysplastic and neoplastic lesions from non dysplastic and neoplastic lesions: a cross-sectional study. J Biomed Opt 19(7):76003. https://doi.org/10.1117/1.jbo.19.7.076003CrossRefPubMed

45.

Ibrahim SS, Al-Attas SA, Darwish ZE, Amer HA, Hassan MH (2014) Effectiveness of the Microlux/DLTM chemiluminescence device in screening of potentially malignant and malignant oral lesions. Asian Pac J Cancer Prev 15:6081–6086. https://doi.org/10.7314/apjcp.2014.15.15.6081CrossRefPubMed

46.

Ujaoney S, Motwani M, Degwekar S, Wadhwan V, Zade P, Chaudhary M, Hazarey V, Thakre T, Mamtani M (2012) Evaluation of chemiluminescence, toluidine blue and histopathology for detection of high risk oral precancerous lesions: a cross-sectional study. BMC Clin Pathol 12:6. https://doi.org/10.1186/1472-6890-12-6CrossRefPubMedPubMedCentral

47.

Vashisht N, Ravikiran A, Samatha Y, Chandra Rao P, Naik R, Vashisht D (2014) Chemiluminescence and toluidine blue as diagnostic tools for detecting early stages of oral cancer: an invivo study. J Clin Diagn Res 8(4):ZC35–ZC38. https://doi.org/10.7860/JCDR/2014/7746.4259CrossRefPubMedPubMedCentral

48.

Rana M, Zapf A, Kuehle M, Gellrich NC, Eckardt AM (2012) Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study. Eur J Cancer Prev 21(5):460–466. https://doi.org/10.1097/CEJ.0b013e32834fdb6dCrossRefPubMed

49.

Epstein JB, Silverman S, Epstein JD, Lonky SA, Bride MA (2008) Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol 44(6):538–544. https://doi.org/10.1016/j.oraloncology.2007.08.011CrossRefPubMed

50.

Ram S, Siar CH (2005) Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 34(5):521–527. https://doi.org/10.1016/j.ijom.2004.10.008CrossRefPubMed

51.

Zheng W, Soo KC, Sivanandan R, Olivo M (2002) Detection of squamous cell carcinomas and pre-cancerous lesions in the oral cavity by quantification of 5-aminolevulinic acid induced fluorescence endoscopic images. Lasers Surg Med 31(3):151–157. https://doi.org/10.1002/lsm.10105CrossRefPubMed

52.

Leunig A, Betz CS, Mehlmann M, Stepp H, Arbogast S, Grevers G, Baumgartner R (2000) Detection of squamous cell carcinoma of the oral cavity by imaging 5- aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope 172(6):674–677. https://doi.org/10.1097/00005537-200001000-00015CrossRef

53.

Kulapaditharom B, Boonkitticharoen V (1998) Laser-induced fluorescence imaging in localization of head and neck cancers. Ann Otol Rhinol Laryngol 110(1):45–52. https://doi.org/10.1177/000348949810700310CrossRef

54.

Allegra E, Lombardo N, Puzzo L, Garozzo A (2009) The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions. Acta Otorhinolaryngol Ital 29(4):187–190. https://doi.org/10.1177/000348940111000109CrossRefPubMedPubMedCentral

55.

Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, Shukla P (2010) A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc 141(2):151–156. https://doi.org/10.14219/jada.archive.2010.0132CrossRefPubMed

56.

Awan KH, Morgan PR, Warnakulasuriya S (2011) Utility of chemiluminescence (ViziLiteTM) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med 40(7):541–544. https://doi.org/10.1111/j.1600-0714.2011.01048.xCrossRefPubMed

57.

Amirchaghmaghi M, Mohtasham N, Delavarian Z, Shakeri MT, Hatami M, Mosannen Mozafari P (2018) The diagnostic value of the native fluorescence visualization device for early detection of premalignant/malignant lesions of the oral cavity. Photodiagn Photodyn Ther 21:19–27. https://doi.org/10.1016/j.pdpdt.2017.10.019CrossRef

58.

Shi L, Li C, Shen X, Zhou Z, Liu W, Tang G (2019) Potential role of autofluorescence imaging in determining biopsy of oral potentially malignant disorders: a large prospective diagnostic study. Oral Oncol 98:176–179. https://doi.org/10.1016/j.oraloncology.2019.08.006CrossRefPubMed

59.

Simonato LE, Tomo S, Scarparo Navarro R, Balbin Villaverde AGJ (2019) Fluorescence visualization improves the detection of oral, potentially malignant, disorders in population screening. Photodiagn Photodyn Ther 27:74–78. https://doi.org/10.1016/j.pdpdt.2019.05.017CrossRef

60.

Farah CS, McCullough MJ (2007) A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions. Oral Oncol 43(8):820–824. https://doi.org/10.1016/j.oraloncology.2006.10.005CrossRefPubMed

61.

Shukla A, Singh NN, Adsul S, Kumar S, Shukla D, Sood A (2018) Comparative efficacy of chemiluminescence and toluidine blue in the detection of potentially malignant and malignant disorders of the oral cavity. J Oral Maxillofac Pathol 22(3):442. https://doi.org/10.4103/jomfp.JOMFP_261_17CrossRefPubMedPubMedCentral

62.

Rajmohan M, Rao UK, Joshua E, Rajasekaran ST, Kannan R (2012) Assessment of oral mucosa in normal, precancer and cancer using chemiluminescent illumination, toluidine blue supravital staining and oral exfoliative cytology. J Oral Maxillofac Pathol 16(3):325–329. https://doi.org/10.4103/0973-029X.102476CrossRefPubMedPubMedCentral

63.

Rashid A, Warnakulasuriya S (2015) The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review. J Oral Pathol Med 21(4):e447–e455. https://doi.org/10.1111/jop.12218CrossRef

64.

Fuller C, Camilon R, Nguyen S, Jennings J, Day T, Gillespie MB (2015) Adjunctive diagnostic techniques for oral lesions of unknown malignant potential: systematic review with meta-analysis. Head Neck 37(5):755–762. https://doi.org/10.1002/hed.23667CrossRefPubMed

65.

Walsh T, Liu JLY, Brocklehurst P, Glenny AM, Lingen M, Kerr AR, Ogden G, Warnakulasuriya S, Scully C (2013) Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev 11:CD010173. https://doi.org/10.1002/14651858.CD010173.pub2CrossRef

66.

Lingen MW, Tampi MP, Urquhart O et al (2017) Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: diagnostic test accuracy systematic review and meta-analysis—a report of the American Dental Association. J Am Dent Assoc 148(11):797–813.e52. https://doi.org/10.1016/j.adaj.2017.08.045CrossRefPubMedPubMedCentral

67.

Kim DH, Song EA, Kim SW, Hwang SH (2020) Efficacy of toluidine blue in the diagnosis and screening of oral cancer and precancer: A systematic review and meta-analysis. Clin Otolaryngol (Aug 1). https://doi.org/10.1111/coa.13613

Titel: Diagnostic accuracy of clinical visualization and light-based tests in precancerous and cancerous lesions of the oral cavity and oropharynx: a systematic review and meta-analysis
verfasst von: María Rosa Buenahora
Alberto Peraza-L
David Díaz-Báez
Jairo Bustillo
Iván Santacruz
Tamy Goretty Trujillo
Gloria Inés Lafaurie
Leandro Chambrone
Publikationsdatum: 03.01.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 6/2021
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-020-03746-y

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Diagnostic accuracy of clinical visualization and light-based tests in precancerous and cancerous lesions of the oral cavity and oropharynx: a systematic review and meta-analysis